ArticleThe American journal of clinical nutrition2007
Symposium introduction: metabolic syndrome and the onset of cancer.
Article in The American journal of clinical nutrition, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 65 citations in OpenAlex.
- The association between metabolic syndrome and the risk of prostate cancer, high-grade prostate cancer, advanced prostate cancer, prostate cancer-specific mortality and biochemical recurrence.Journal of experimental & clinical cancer research : CR · 2013Pooled it
- Metabolic syndrome and risk of cancer: a systematic review and meta-analysis.Diabetes care · 2012Pooled it
- A low-fat dietary pattern and risk of metabolic syndrome in postmenopausal women: the Women's Health Initiative.Metabolism: clinical and experimental · 2012Trial
- Low glycemic load experimental diet more satiating than high glycemic load diet.Nutrition and cancer · 2012Trial
- Finasteride modifies the relation between serum C-peptide and prostate cancer risk: results from the Prostate Cancer Prevention Trial.Cancer prevention research (Philadelphia, Pa.) · 2010Trial
- Breast Cancer and Cardiovascular Risk: The Role of Dyslipidemia, Inflammation and Obesity.Diagnostics (Basel, Switzerland) · 2026Review
- Associations of combined lifestyle and metabolic risks with cancer incidence in the UK biobank study.BMC cancer · 2025Article
- Novel metabolic prognostic score for predicting survival in patients with cancer.Scientific reports · 2025Article
- Article
- The combination of metabolic syndrome and inflammation increased the risk of colorectal cancer.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2022Article
- Protective and therapeutic role of mango pulp and eprosartan drug and their anti-synergistic effects against thioacetamide-induced hepatotoxicity in male rats.Environmental science and pollution research international · 2022Article
- The impact of the microbiome in cancer: Targeting metabolism of cancer cells and host.Frontiers in oncology · 2022Review
- Risk Factors of Young-Onset Colorectal Cancer: Analysis of a Large Population-Based Registry.Canadian journal of gastroenterology & hepatology · 2022Article
- The Importance of Metabolic Syndrome Status for the Risk of Non-Viral Hepatocellular Carcinoma: A Nationwide Population-Based Study.Frontiers in oncology · 2022Article
- The synergistic hepatoprotective potential of Beta vulgaris juice and 2,3- dimercaptosuccinic acid in lead-intoxicated rats via improving the hepatic oxidative and inflammatory stress.BMC complementary medicine and therapies · 2020Article
- Association of gout and colorectal cancer in Taiwan: a nationwide population-based cohort study.BMJ open · 2019Article
- Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies.Hepatology (Baltimore, Md.) · 2018Article
- A stage-dependent link between metabolic syndrome components and incident prostate cancer.Nature reviews. Urology · 2018Review
- In-Hospital Mortality and Post-Surgical Complications Among Cancer Patients with Metabolic Syndrome.Obesity surgery · 2018Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
Diabetes, obesity, and related metabolic disorders are among the most pressing of today's health care concerns. Recent evidence from epidemiologic and basic research studies, as well as translational, clinical, and intervention studies, supports the emerging hypothesis that metabolic syndrome may be an important etiologic factor for the onset of cancer. On March 15-16, 2006, The Harvard Medical School Division of Nutrition hosted the symposium "Metabolic Syndrome and the Onset of Cancer" as a platform to systematically evaluate the evidence in support of this hypothesis. This symposium, which gathered leaders in the fields of metabolism, nutrition, and cancer, will stimulate further research investigating the etiologic role of metabolic syndrome in cancer. Furthermore, it will help to guide the development of effective cancer prevention strategies via nutritional and lifestyle modifications to alleviate metabolic syndrome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.